Evaluation of the prevalence of Systolic hypertension in Persian cats with poly cystic kidney disease
الموضوعات :
Niloufar Saberi
1
,
Ehsan Khaksar
2
,
Mohammad Molazem
3
,
Siamak Mashhadi Rafiee
4
1 - Department of Clinical Science, Science and Research Branch, Islamic Azad University, Tehran, Iran
2 - Department of Clinical Sciences, Garmsar Branch, Islamic Azad University, Garmsar, Iran
3 - Department of Veterinary Surgery and Diagnostic Imaging, Faculty of Veterinary Medicine, Tehran University, Tehran, Iran
4 - Department of Clinical Science, Science and Research Branch, Islamic Azad University, Tehran, Iran
الکلمات المفتاحية: Persian cats, Polycystic kidney disease, Systolic hypertension, Prevalence, Doppler Ultrasonography ,
ملخص المقالة :
Polycystic kidney disease (PKD) is a genetic disorder prevalent in Persian and Persian-related cat breeds. It often leads to systemic arterial hypertension, which can severely affect the kidneys and heart if not managed. This study aimed to assess the prevalence of hypertension in Persian cats with PKD. Conducted at Tehran Azma Veterinary Center from March to May 2023, the research included 24 cats of Persian or Persian-mixed breeds. The cats were divided into two groups based on kidney ultrasonography examinations: a control group and a PKD group, each containing 12 cats. Systolic blood pressure was measured using Doppler ultrasonography and categorized according to the guidelines of the International Renal Interest Society (IRIS). The mean kidney size in cats with PKD was found to be significantly larger than that in the control group (p< 0.05). The average blood pressure of the PKD cats was substantially higher, recorded at 165.0 ± 23.5 mm Hg, with a higher mean in azotemic cats. The study found that 75% of the PKD cats had hypertension, with 25% experiencing severe hypertension, putting them at a high risk of future organ failure. In conclusion, hypertension is highly prevalent in Persian cats with PKD, and the progression of PKD, along with the presence of azotemia, can impact systolic blood pressure. Therefore, proactive strategies and hypertension management should be considered in PKD cats.
[1] Schirrer L, Marín-García PJ, Llobat L. Feline Polycystic Kidney Disease: An Update. Veterinary Sciences. 2021; 8(11): 269.
doi:10.3390/vetsci8110269
[2] Jasik A, Kulesza M. Polycystic kidney disease in a Neva Masquerade cat. Journal of Small Animal Practice. 2014; 55(7): 387-387.
doi:10.1111/jsap.12240
[3] Noori Z, Moosavian HR, Esmaeilzadeh H, Vali Y, Fazli M. Prevalence of polycystic kidney disease in Persian and Persian-related cats referred to Small Animal Hospital, University of Tehran, Iran. Iranian Journal of Veterinary Research. 2019; 20(2): 151-154. doi:10.22099/ijvr.2019.5267
[4] Mae SI, Hattanda F, Morita H, Nozaki A, Katagiri K, Ogawa H, et al. Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD. Cell Reports. 2023; 42(12): 113431.
doi:10.1016/j.celrep.2023.113431
[5] Kimberling WJ, Pieke-Dahl SA, Kumar S. The genetics of cystic diseases of the kidney. Seminars in Nephrology. 1991; 11(6): 596-606.
[6] Saini AK, Saini R, Singh S. Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects. Molecular Medicine. 2020; 26(1): 128.
doi:10.1186/s10020-020-00246-3
[7] Sato R, Uchida N, Kawana Y, Tozuka M, Kobayashi S, Hanyu N, et al. Epidemiological evaluation of cats associated with feline polycystic kidney disease caused by the feline PKD1 genetic mutation in Japan. The Journal of Veterinary Medical Science. 2019; 81(7): 1006-1011. doi:10.1292/jvms.18-0309
[8] Rastogi A, Ameen KM, Al-Baghdadi M, Shaffer K, Nobakht N, Kamgar M, et al. Autosomal dominant polycystic kidney disease: updated perspectives. Therapeutics and Clinical Risk Management. 2019; 15: 1041-1052. doi:10.2147/TCRM.S196244
[9] Bonazzi M, Volta A, Gnudi G, Cozzi MC, Strillacci MG, Polli M, et al. Comparison between ultrasound and genetic testing for the early diagnosis of polycystic kidney disease in Persian and Exotic Shorthair cats. Journal of Feline Medicine and Surgery. 2009; 11(6): 430-434. doi:10.1016/j.jfms.2008.10.003
[10] Moazezi Ghavihelm A, Jamshidi S, Ashrafi Tamai I, Zangisheh M. Molecular detection of polycystic kidney disease in Persian and Persian-related breeds in Iran. Journal of Feline Medicine and Surgery. 2022; 8(1): 205511692110709.
doi:10.1177/20551169211070991
[11] Luciano RL, Dahl NK. Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrology Dialysis Transplantation. 2014; 29(2): 247-254.
doi:10.1093/ndt/gft437
[12] Sans-Atxer L, Torra R, Fernandez-Llama P. Hypertension in autosomal-dominant polycystic kidney disease (ADPKD). Clinical Kidney Journal. 2013; 6(5): 457-463.
doi:10.1093/ckj/sft031
[13] Oto OA, Edelstein CL. The Pathophysiology of left ventricular hypertrophy, beyond hypertension, in autosomal dominant polycystic kidney disease. Nephron. 2022; 1-9. doi:10.1159/000525944
[14] Pietrzak-Nowacka M, Safranow K, Plonska-Gosciniak E, Nowacki A, Pozniak P, Gutowski P, et al. Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review. Kidney and Blood Pressure Research. 2024; 49(1): 9-19. doi:10.1159/000529119
[15] Ratnam S, Nauli SM. Hypertension in autosomal dominant polycystic kidney disease: A clinical and basic science perspective. International Urology and Nephrology. 2010; 2(2): 294-308.
[16] Purina. Body Condition System - Cat, Purina Institute. Accessed: Feb. 11, 2024. [Online]. Available:https://www.purinainstitute.com/sites/default/files/2021-04/body-condition-system-cat.
[17] Brown S, Atkins C, Bagley R, Carr A, Cowgill L, Davidson M, et al. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. Journal of Veterinary Internal Medicine. 2007; 21(3): 542-558.
[18] Payne JR, Brodbelt DC, Luis Fuentes V. Blood pressure measurements in 780 apparently healthy cats. Journal of Veterinary Internal Medicine. 2017; 31(1): 15-21.
doi:10.1111/jvim.14625
[19] IRIS Staging of CKD. International Renal Interest Society. Accessed: Nov. 26, 2023. [Online]. Available: http://www.iris-kidney.com/guidelines/staging.html
[20] Lawson JS, Jepson RE. Feline comorbidities: The intermingled relationship between chronic kidney disease and hypertension. Journal of Feline Medicine and Surgery. 2021; 23(9): 812-822. doi:10.1177/1098612X211037872
[21] Hori Y, Heishima Y, Yamashita Y, Isayama N, Kanno N, Nakamura K, et al. Relationship between indirect blood pressure and various stages of chronic kidney disease in cats. Journal of Veterinary Medical Science. 2018; 80(3): 447-452. doi:10.1292/jvms.17-0620
[22] Morar D, Ciulan V, Simiz F, Petruse C, Pela R, MOŢ T. Arterial blood pressure in cats with polycystic kidney disease. Lucrări Ştiinţifice Medicină Veterinară. 2016; 4: 154-8.
[23] Morar D, Falca C, Mot T, Ciulan V, Simiz F, Brudiu I, et al. Study concerning blood pressure in clinically healthy and conscious cats measured by oscillometric method. University of Agronomical Medical Sciences and Veterinary Medicine-Bucharest. 2009; 2: 288-295.
[24] Pedersen KM, Pedersen HD, Haggstrom J, Koch J, Ersbøll AK. Increased mean arterial pressure and aldosterone‐to‐renin ratio in Persian cats with polycystic kidney
disease. Journal of Veterinary Internal Medicine. 2003; 17(1): 21-27. doi:10.1111/j.1939-1676.2003.tb01319.x
[25] Ecder T, Schrier RW. Hypertension in Autosomal-Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. 2001; 12(1): 194-200.
doi:10.1681/ASN.V121194
[26] Krishnappa V, Vinod P, Deverakonda D, Raina R. Autosomal dominant polycystic kidney disease and its impact on the cardiovascular system and brain. Cleveland Clinic Journal of Medicine. 2017; 84(6): 471-481. doi:10.3949/ccjm.84a.16107
